PCVX Sale Disclosure
Guggenhime Andrew · SEC Form 4 · Filed Aug 5, 2026
Sale
Calculated transaction value
$164.92K
Guggenhime Andrew President And CFO
PCVX
Vaxcyte
PCVX
Transaction date
Aug 3, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 2 days later
PCVX daily price context
Close on/before transaction
$53.53
Aug 3, 2026
Close before public filing
$54.69
Aug 4, 2026
Return since public filing
+6.29%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,044 shares @ $54.18
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001230724-26-000014
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$592.38K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vaxcyte, Inc. PCVX | Exercise | Aug 3, 2026 | $53.5K |
| Vaxcyte, Inc. PCVX | Sale | Aug 3, 2026 | $373.96K |
| Vaxcyte, Inc. PCVX | Exercise | Aug 3, 2026 | $0 |
| Vaxcyte, Inc. PCVX Current | Sale | Aug 3, 2026 | $164.92K |